Standout Papers

LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study 2022 2026 2023 2024124
  1. LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study (2022)
    Myriam Chalabi, Y.L. Verschoor et al. Annals of Oncology

Immediate Impact

29 standout
Sub-graph 1 of 12

Citing Papers

Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Invasion and metastasis in cancer: molecular insights and therapeutic targets
2025 Standout
1 intermediate paper

Works of Eduard R. Hendriks being referenced

LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study
2022 Standout

Author Peers

Author Last Decade Papers Cites
Eduard R. Hendriks 147 217 55 81 8 276
Torhild Veen 104 107 45 80 7 233
Elizabeth Levin 176 84 41 97 9 329
Miguel Oviedo 164 213 63 24 8 324
Berkant Sönmez 86 81 63 36 10 234
Alvise Frasson 55 122 213 58 7 261
R Tomin 47 80 61 44 12 240
Robert Brownlee 76 135 154 46 7 279
Granada Perea 25 70 34 45 12 267
Andrea Barina 94 169 62 28 13 250
D B Calandra 108 83 52 18 10 334

All Works

Loading papers...

Rankless by CCL
2026